During the past decade, Accellacare - (MeDiNova Limited) - North London conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Accellacare - (MeDiNova Limited) - North London" #1 sponsor was "Amgen" with 1 trials, followed by "Averitas Pharma, Inc." with 1 trials sponsored, "Danisco" with 1 trials sponsored, "Estetra" with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Accellacare - (MeDiNova Limited) - North London" #1 collaborator was "4Pharma Ltd." with 1 trials as a collaborator, "Daacro" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Accellacare - (MeDiNova Limited) - North London" are "Coronary Heart Disease (CHD)" (1 trials), "Healthy" (1 trials), "Menopausal Symptoms" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Accellacare - (MeDiNova Limited) - North London" in a lesser frequency.

Most popular intervention types in "Accellacare - (MeDiNova Limited) - North London" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Estetrol oral tablet" (1 trials), "Evolocumab" (1 trials), "Fasinumab" (1 trials) and "Fasinumab-matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Accellacare - (MeDiNova Limited) - North London" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Accellacare - (MeDiNova Limited) - North London". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Accellacare - (MeDiNova Limited) - North London, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Accellacare - (MeDiNova Limited) - North London, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".